AMGEN Inc
NASDAQ: AMGN
$262.65
-$0.53 (-0.2%)
Closing Price on December 27, 2024
AMGN Articles
The June 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has...
Published:
Last Updated:
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
Published:
Last Updated:
Coherus Biosciences saw its shares crater on Monday after the company announced that it received a complete response letter from the FDA regarding its biologics license application for a...
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The April 28 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Boeing, PepsiCo and other top companies scheduled to report their quarterly results on Wednesday.
Published:
Last Updated:
The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Published:
Last Updated:
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include American Express, Amgen, Encana, Gilead Science and Tesla.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
Published:
Last Updated: